Drägerwerk AG & Co. KGaA Total Assets

Latest as of September 2025: €3.03 Billion EUR ≈ $3.54 Billion USD

Drägerwerk AG & Co. KGaA total assets. Based on the latest financial reports, Drägerwerk AG & Co. KGaA (DRW8) holds total assets worth €3.03 Billion EUR (≈ $3.54 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Drägerwerk AG & Co. KGaA (DRW8) market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Drägerwerk AG & Co. KGaA (2005–2024)

Total assets of Drägerwerk AG & Co. KGaA from 2005 to 2024. This chart illustrates how Drägerwerk AG & Co. KGaA's total assets have evolved over time, based on quarterly financial data. See Drägerwerk AG & Co. KGaA (DRW8) share price today for real-time trading data and today's change.

Drägerwerk AG & Co. KGaA - Asset Composition Analysis

Drägerwerk AG & Co. KGaA Total Assets Breakdown (December 2024)

Drägerwerk AG & Co. KGaA total assets breakdown as of December 2024. Drägerwerk AG & Co. KGaA's total assets of €3.03 Billion consist of 60.9% current assets and 39.1% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €223.47 Million 7.2%
Accounts Receivable €857.80 Million 27.7%
Inventory €654.34 Million 21.2%
Property, Plant & Equipment €548.98 Million 17.8%
Intangible Assets €30.70 Million 1.0%
Goodwill €312.15 Million 10.1%

Asset Composition Trend (2005–2024)

This chart illustrates how Drägerwerk AG & Co. KGaA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore DRW8 net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Drägerwerk AG & Co. KGaA's current assets represent 60.9% of total assets in 2024, a decrease from 68.9% in 2005.
  • Cash Position: Cash and equivalents constituted 7.2% of total assets in 2024, down from 11.9% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 0.0% in 2005.
  • Asset Diversification: The largest asset category is accounts receivable at 27.7% of total assets.

Drägerwerk AG & Co. KGaA Competitors by Total Assets

Key competitors of Drägerwerk AG & Co. KGaA based on total assets are shown below.

Company Country Total Assets
Demant A/S
CO:DEMANT
Denmark Dkr39.07 Billion
Shanghai Sanyou Medical Co Ltd
SHG:688085
China CN¥2.34 Billion
CareRay Digital Medical Technology Co Ltd
SHG:688607
China CN¥988.48 Million
PULSION Medical Systems SE
MU:PUS
Germany €35.15 Million
Cleo Diagnostics Ltd
AU:COV
Australia AU$9.96 Million
Memphasys Ltd
AU:MEM
Australia AU$10.45 Million
Cochlear Ltd
AU:COH
Australia AU$2.83 Billion
4DMEDICAL Ltd
AU:4DX
Australia AU$139.55 Million

Drägerwerk AG & Co. KGaA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.76 1.89 1.86
Quick Ratio 1.03 1.10 1.33
Cash Ratio 0.19 0.19 0.00
Working Capital €770.95 Million €845.02 Million €994.11 Million

Drägerwerk AG & Co. KGaA - Advanced Valuation Insights

This section examines the relationship between Drägerwerk AG & Co. KGaA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.88
Latest Market Cap to Assets Ratio 0.30
Asset Growth Rate (YoY) 0.0%
Total Assets €3.09 Billion
Market Capitalization $919.37 Million USD

Valuation Analysis

Below Book Valuation: The market values Drägerwerk AG & Co. KGaA's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Drägerwerk AG & Co. KGaA's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Drägerwerk AG & Co. KGaA (2005–2024)

The table below shows the annual total assets of Drägerwerk AG & Co. KGaA from 2005 to 2024.

Year Total Assets Change
2024-12-31 €3.09 Billion
≈ $3.62 Billion
-0.04%
2023-12-31 €3.09 Billion
≈ $3.62 Billion
-0.39%
2022-12-31 €3.11 Billion
≈ $3.63 Billion
-2.26%
2021-12-31 €3.18 Billion
≈ $3.72 Billion
-3.86%
2020-12-31 €3.31 Billion
≈ $3.87 Billion
+28.59%
2019-12-31 €2.57 Billion
≈ $3.01 Billion
+6.67%
2018-12-31 €2.41 Billion
≈ $2.82 Billion
+2.37%
2017-12-31 €2.35 Billion
≈ $2.75 Billion
+1.82%
2016-12-31 €2.31 Billion
≈ $2.70 Billion
+0.04%
2015-12-31 €2.31 Billion
≈ $2.70 Billion
+3.46%
2014-12-31 €2.23 Billion
≈ $2.61 Billion
+8.19%
2013-12-31 €2.07 Billion
≈ $2.41 Billion
-1.72%
2012-12-31 €2.10 Billion
≈ $2.46 Billion
-0.66%
2011-12-31 €2.12 Billion
≈ $2.47 Billion
+6.99%
2010-12-31 €1.98 Billion
≈ $2.31 Billion
+4.83%
2009-12-31 €1.89 Billion
≈ $2.20 Billion
+13.96%
2008-12-31 €1.65 Billion
≈ $1.93 Billion
+1.06%
2007-12-31 €1.64 Billion
≈ $1.91 Billion
+0.08%
2006-12-31 €1.64 Billion
≈ $1.91 Billion
+6.51%
2005-12-31 €1.54 Billion
≈ $1.80 Billion
--

About Drägerwerk AG & Co. KGaA

XETRA:DRW8 Germany Medical Devices
Market Cap
$919.37 Million
€786.38 Million EUR
Market Cap Rank
#8933 Global
#1156 in Germany
Share Price
€77.40
Change (1 day)
-0.26%
52-Week Range
€55.60 - €94.20
All Time High
€94.20
About

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more